Skip to content
Discover insights into northern cultures, travel tips, and …

Zimbabwe Turns Down ‘Unbalanced’ US Health Aid Package Due to Data Fears

Health funding illustration
The proposed US funding was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has rejected a major American health deal valued at 367 million US dollars (272 million pounds) over five years due to Washington's request for sensitive biological samples.

The decision became public after a government memo from December was disclosed, revealing that President Emmerson Mnangagwa believed the agreement was "unbalanced".

A government spokesperson has since stated that the United States was demanding access to genetic material for scientific study and commercial gain while was not willing to share the benefits from any future treatments.

"We will now turn to the difficult and regrettable task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the United States had provided over $1.9bn in health funding to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has called for continued negotiations to secure a agreement suitable to all parties so the nation's vital HIV treatment initiative can proceed.

Wider Implications

This development comes after a comparable situation in Kenya, where a court halted a similar health funding agreement after legal challenges were raised about the safety of citizens' medical information.

After returning to office recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).

USAID had overseen aid for the American government, but Trump stated its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance transparency and responsibility.

Based on reports, Sixteen nations in Africa have to date signed these new health pacts, representing more than $18.3bn of fresh investment.

Specifics of the Rejected Agreement

This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this cooperation would have delivered significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded programmes," the Ambassador commented.

However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, with no equivalent assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.

"Put simply, our country would supply the raw materials for medical research without any assurance that the final treatments would be accessible to our citizens should a new pandemic arise."

Sovereignty and Global Health

He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining systems previously established via the global organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with future pandemics.

"This system is intended to guarantee that when a country provides its information, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."

These objections regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We are open to ongoing dialogue with our US partners on how future co-operation might be arranged in a way that respects the sovereignty and dignity of both nations."

Health Experts Reaction

Medical experts expressed it understood the government's concerns, but recommended that negotiations must proceed given that much of the nation's Aids initiatives relied on international support.

"If technical issues exist, such as those relating to data governance or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," it said.

The halted deal underscores the ongoing challenges between receiving crucial international aid and safeguarding national sovereignty in an increasingly interconnected world.

By

Cynthia Harrison

A cultural anthropologist and travel writer with over a decade of experience documenting Arctic and subarctic communities.

North World

Type to search articles.